Research Investment/Funding

Current FOSEP leaders: Renee Agatsuma, Cyan James, Bish Paul, Abigail G. Schindler, PhD, Corey Snelson, PhD, Christopher Terai. (James and Schindler are the main authors)

Dear Research Advocate:

The Bureau of Economic Analysis has reclassified research and development costs from an “expense” to an “investment” when calculating GDP. We think Members of Congress should do the same. Common sense tells us R&D is an investment, not an expense; in general conversation we all talk about R&D as an investment, but it isn’€™t accounted for that way on the federal books. The arguments we’€™ve been making are now further bolstered by the BEA’€™s decision. Spread the word!

Dear Research Advocate:

Mary on Aljazeera government shutdown 10-18-13

Dear Research Advocate:

Dear Research Advocate:

Statement by Research!America President and CEO Mary Woolley on Nobel Prize in Physiology or Medicine

October 7, 2013

pinkribbonIt’€™s Breast Cancer Awareness Month! Although many great strides in new treatments and therapies for breast cancer have been made, patients and their families are still waiting desperately for a cure.

Dear Research Advocate:

Recent polling commissioned by Research!America shows nearly half of the American public does not believe we are making enough progress in medical research in the U.S.; the government shutdown proves them right. The shutdown shows where the real deficit is: in the failure of elected officials to take action to fund American priorities. The deficit seems to be a deficit of common sense!

Pages

Subscribe to RSS - Research Investment/Funding